Global Subcutaneous Drug Delivery Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Subcutaneous Drug Delivery Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 90

Published Date: 11 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

A subcutaneous drug delivery device having a housing having an internal reservoir in communication with a drug delivery needle via a fluid path. An expandable chamber disposed adjacent to the reservoir forces drug from the reservoir to the needle when supplied with a gas.

According to our (Global Info Research) latest study, the global Subcutaneous Drug Delivery Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Subcutaneous Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Subcutaneous Drug Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Subcutaneous Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Subcutaneous Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Subcutaneous Drug Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Subcutaneous Drug Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Subcutaneous Drug Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Insulet Corporation, Enable Injections, West Pharmaceutical Services, Inc and Ypsomed AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Subcutaneous Drug Delivery Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Prefilled Injectable
Filled Injectable

Market segment by Application
Hospitals
Clinics
Others

Major players covered
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Subcutaneous Drug Delivery Devices, with price, sales, revenue and global market share of Subcutaneous Drug Delivery Devices from 2018 to 2023.
Chapter 3, the Subcutaneous Drug Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Subcutaneous Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Subcutaneous Drug Delivery Devices.
Chapter 14 and 15, to describe Subcutaneous Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Subcutaneous Drug Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Subcutaneous Drug Delivery Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prefilled Injectable
1.3.3 Filled Injectable
1.4 Market Analysis by Application
1.4.1 Overview: Global Subcutaneous Drug Delivery Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Subcutaneous Drug Delivery Devices Market Size & Forecast
1.5.1 Global Subcutaneous Drug Delivery Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Subcutaneous Drug Delivery Devices Sales Quantity (2018-2029)
1.5.3 Global Subcutaneous Drug Delivery Devices Average Price (2018-2029)

2 Manufacturers Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Subcutaneous Drug Delivery Devices Product and Services
2.1.4 BD Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BD Recent Developments/Updates
2.2 Insulet Corporation
2.2.1 Insulet Corporation Details
2.2.2 Insulet Corporation Major Business
2.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services
2.2.4 Insulet Corporation Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Insulet Corporation Recent Developments/Updates
2.3 Enable Injections
2.3.1 Enable Injections Details
2.3.2 Enable Injections Major Business
2.3.3 Enable Injections Subcutaneous Drug Delivery Devices Product and Services
2.3.4 Enable Injections Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Enable Injections Recent Developments/Updates
2.4 West Pharmaceutical Services, Inc
2.4.1 West Pharmaceutical Services, Inc Details
2.4.2 West Pharmaceutical Services, Inc Major Business
2.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services
2.4.4 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 West Pharmaceutical Services, Inc Recent Developments/Updates
2.5 Ypsomed AG
2.5.1 Ypsomed AG Details
2.5.2 Ypsomed AG Major Business
2.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services
2.5.4 Ypsomed AG Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ypsomed AG Recent Developments/Updates
2.6 Elcam Medical
2.6.1 Elcam Medical Details
2.6.2 Elcam Medical Major Business
2.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Product and Services
2.6.4 Elcam Medical Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Elcam Medical Recent Developments/Updates
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Subcutaneous Drug Delivery Devices Product and Services
2.7.4 Amgen Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Amgen Recent Developments/Updates
2.8 Wilhelm Haselmeier
2.8.1 Wilhelm Haselmeier Details
2.8.2 Wilhelm Haselmeier Major Business
2.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services
2.8.4 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Wilhelm Haselmeier Recent Developments/Updates

3 Competitive Environment: Subcutaneous Drug Delivery Devices by Manufacturer
3.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2018-2023)
3.3 Global Subcutaneous Drug Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Subcutaneous Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Subcutaneous Drug Delivery Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Subcutaneous Drug Delivery Devices Manufacturer Market Share in 2022
3.5 Subcutaneous Drug Delivery Devices Market: Overall Company Footprint Analysis
3.5.1 Subcutaneous Drug Delivery Devices Market: Region Footprint
3.5.2 Subcutaneous Drug Delivery Devices Market: Company Product Type Footprint
3.5.3 Subcutaneous Drug Delivery Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Subcutaneous Drug Delivery Devices Market Size by Region
4.1.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2029)
4.1.3 Global Subcutaneous Drug Delivery Devices Average Price by Region (2018-2029)
4.2 North America Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)
4.3 Europe Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)
4.5 South America Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
5.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Type (2018-2029)
5.3 Global Subcutaneous Drug Delivery Devices Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
6.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Application (2018-2029)
6.3 Global Subcutaneous Drug Delivery Devices Average Price by Application (2018-2029)

7 North America
7.1 North America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
7.2 North America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
7.3 North America Subcutaneous Drug Delivery Devices Market Size by Country
7.3.1 North America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
8.2 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
8.3 Europe Subcutaneous Drug Delivery Devices Market Size by Country
8.3.1 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Subcutaneous Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
10.2 South America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
10.3 South America Subcutaneous Drug Delivery Devices Market Size by Country
10.3.1 South America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Subcutaneous Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Subcutaneous Drug Delivery Devices Market Drivers
12.2 Subcutaneous Drug Delivery Devices Market Restraints
12.3 Subcutaneous Drug Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Subcutaneous Drug Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Subcutaneous Drug Delivery Devices
13.3 Subcutaneous Drug Delivery Devices Production Process
13.4 Subcutaneous Drug Delivery Devices Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Subcutaneous Drug Delivery Devices Typical Distributors
14.3 Subcutaneous Drug Delivery Devices Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Subcutaneous Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Subcutaneous Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BD Basic Information, Manufacturing Base and Competitors
Table 4. BD Major Business
Table 5. BD Subcutaneous Drug Delivery Devices Product and Services
Table 6. BD Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BD Recent Developments/Updates
Table 8. Insulet Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Insulet Corporation Major Business
Table 10. Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services
Table 11. Insulet Corporation Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Insulet Corporation Recent Developments/Updates
Table 13. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 14. Enable Injections Major Business
Table 15. Enable Injections Subcutaneous Drug Delivery Devices Product and Services
Table 16. Enable Injections Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Enable Injections Recent Developments/Updates
Table 18. West Pharmaceutical Services, Inc Basic Information, Manufacturing Base and Competitors
Table 19. West Pharmaceutical Services, Inc Major Business
Table 20. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services
Table 21. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. West Pharmaceutical Services, Inc Recent Developments/Updates
Table 23. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 24. Ypsomed AG Major Business
Table 25. Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services
Table 26. Ypsomed AG Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ypsomed AG Recent Developments/Updates
Table 28. Elcam Medical Basic Information, Manufacturing Base and Competitors
Table 29. Elcam Medical Major Business
Table 30. Elcam Medical Subcutaneous Drug Delivery Devices Product and Services
Table 31. Elcam Medical Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Elcam Medical Recent Developments/Updates
Table 33. Amgen Basic Information, Manufacturing Base and Competitors
Table 34. Amgen Major Business
Table 35. Amgen Subcutaneous Drug Delivery Devices Product and Services
Table 36. Amgen Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Amgen Recent Developments/Updates
Table 38. Wilhelm Haselmeier Basic Information, Manufacturing Base and Competitors
Table 39. Wilhelm Haselmeier Major Business
Table 40. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services
Table 41. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Wilhelm Haselmeier Recent Developments/Updates
Table 43. Global Subcutaneous Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Subcutaneous Drug Delivery Devices Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 46. Market Position of Manufacturers in Subcutaneous Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Subcutaneous Drug Delivery Devices Production Site of Key Manufacturer
Table 48. Subcutaneous Drug Delivery Devices Market: Company Product Type Footprint
Table 49. Subcutaneous Drug Delivery Devices Market: Company Product Application Footprint
Table 50. Subcutaneous Drug Delivery Devices New Market Entrants and Barriers to Market Entry
Table 51. Subcutaneous Drug Delivery Devices Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Subcutaneous Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Subcutaneous Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Subcutaneous Drug Delivery Devices Average Price by Region (2018-2023) & (USD/Unit)
Table 57. Global Subcutaneous Drug Delivery Devices Average Price by Region (2024-2029) & (USD/Unit)
Table 58. Global Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Subcutaneous Drug Delivery Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Subcutaneous Drug Delivery Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Subcutaneous Drug Delivery Devices Average Price by Type (2018-2023) & (USD/Unit)
Table 63. Global Subcutaneous Drug Delivery Devices Average Price by Type (2024-2029) & (USD/Unit)
Table 64. Global Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Subcutaneous Drug Delivery Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Subcutaneous Drug Delivery Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Subcutaneous Drug Delivery Devices Average Price by Application (2018-2023) & (USD/Unit)
Table 69. Global Subcutaneous Drug Delivery Devices Average Price by Application (2024-2029) & (USD/Unit)
Table 70. North America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Subcutaneous Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Subcutaneous Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Subcutaneous Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Subcutaneous Drug Delivery Devices Raw Material
Table 111. Key Manufacturers of Subcutaneous Drug Delivery Devices Raw Materials
Table 112. Subcutaneous Drug Delivery Devices Typical Distributors
Table 113. Subcutaneous Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Subcutaneous Drug Delivery Devices Picture
Figure 2. Global Subcutaneous Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Type in 2022
Figure 4. Prefilled Injectable Examples
Figure 5. Filled Injectable Examples
Figure 6. Global Subcutaneous Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Others Examples
Figure 11. Global Subcutaneous Drug Delivery Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Subcutaneous Drug Delivery Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Subcutaneous Drug Delivery Devices Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Subcutaneous Drug Delivery Devices Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Subcutaneous Drug Delivery Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Subcutaneous Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Subcutaneous Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Subcutaneous Drug Delivery Devices Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Subcutaneous Drug Delivery Devices Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Subcutaneous Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Subcutaneous Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 53. China Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Subcutaneous Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Subcutaneous Drug Delivery Devices Market Drivers
Figure 74. Subcutaneous Drug Delivery Devices Market Restraints
Figure 75. Subcutaneous Drug Delivery Devices Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Devices in 2022
Figure 78. Manufacturing Process Analysis of Subcutaneous Drug Delivery Devices
Figure 79. Subcutaneous Drug Delivery Devices Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Subcutaneous Drug Delivery Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Subcutaneous Drug Delivery Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 90

Published Date: 11 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

A subcutaneous drug delivery device having a housing having an internal reservoir in communication with a drug delivery needle via a fluid path. An expandable chamber disposed adjacent to the reservoir forces drug from the reservoir to the needle when supplied with a gas.

According to our (Global Info Research) latest study, the global Subcutaneous Drug Delivery Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Subcutaneous Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Subcutaneous Drug Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Subcutaneous Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Subcutaneous Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Subcutaneous Drug Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Subcutaneous Drug Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Subcutaneous Drug Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Insulet Corporation, Enable Injections, West Pharmaceutical Services, Inc and Ypsomed AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Subcutaneous Drug Delivery Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Prefilled Injectable
Filled Injectable

Market segment by Application
Hospitals
Clinics
Others

Major players covered
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Subcutaneous Drug Delivery Devices, with price, sales, revenue and global market share of Subcutaneous Drug Delivery Devices from 2018 to 2023.
Chapter 3, the Subcutaneous Drug Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Subcutaneous Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Subcutaneous Drug Delivery Devices.
Chapter 14 and 15, to describe Subcutaneous Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Subcutaneous Drug Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Subcutaneous Drug Delivery Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prefilled Injectable
1.3.3 Filled Injectable
1.4 Market Analysis by Application
1.4.1 Overview: Global Subcutaneous Drug Delivery Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Subcutaneous Drug Delivery Devices Market Size & Forecast
1.5.1 Global Subcutaneous Drug Delivery Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Subcutaneous Drug Delivery Devices Sales Quantity (2018-2029)
1.5.3 Global Subcutaneous Drug Delivery Devices Average Price (2018-2029)

2 Manufacturers Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Subcutaneous Drug Delivery Devices Product and Services
2.1.4 BD Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BD Recent Developments/Updates
2.2 Insulet Corporation
2.2.1 Insulet Corporation Details
2.2.2 Insulet Corporation Major Business
2.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services
2.2.4 Insulet Corporation Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Insulet Corporation Recent Developments/Updates
2.3 Enable Injections
2.3.1 Enable Injections Details
2.3.2 Enable Injections Major Business
2.3.3 Enable Injections Subcutaneous Drug Delivery Devices Product and Services
2.3.4 Enable Injections Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Enable Injections Recent Developments/Updates
2.4 West Pharmaceutical Services, Inc
2.4.1 West Pharmaceutical Services, Inc Details
2.4.2 West Pharmaceutical Services, Inc Major Business
2.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services
2.4.4 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 West Pharmaceutical Services, Inc Recent Developments/Updates
2.5 Ypsomed AG
2.5.1 Ypsomed AG Details
2.5.2 Ypsomed AG Major Business
2.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services
2.5.4 Ypsomed AG Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ypsomed AG Recent Developments/Updates
2.6 Elcam Medical
2.6.1 Elcam Medical Details
2.6.2 Elcam Medical Major Business
2.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Product and Services
2.6.4 Elcam Medical Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Elcam Medical Recent Developments/Updates
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Subcutaneous Drug Delivery Devices Product and Services
2.7.4 Amgen Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Amgen Recent Developments/Updates
2.8 Wilhelm Haselmeier
2.8.1 Wilhelm Haselmeier Details
2.8.2 Wilhelm Haselmeier Major Business
2.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services
2.8.4 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Wilhelm Haselmeier Recent Developments/Updates

3 Competitive Environment: Subcutaneous Drug Delivery Devices by Manufacturer
3.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2018-2023)
3.3 Global Subcutaneous Drug Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Subcutaneous Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Subcutaneous Drug Delivery Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Subcutaneous Drug Delivery Devices Manufacturer Market Share in 2022
3.5 Subcutaneous Drug Delivery Devices Market: Overall Company Footprint Analysis
3.5.1 Subcutaneous Drug Delivery Devices Market: Region Footprint
3.5.2 Subcutaneous Drug Delivery Devices Market: Company Product Type Footprint
3.5.3 Subcutaneous Drug Delivery Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Subcutaneous Drug Delivery Devices Market Size by Region
4.1.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2029)
4.1.3 Global Subcutaneous Drug Delivery Devices Average Price by Region (2018-2029)
4.2 North America Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)
4.3 Europe Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)
4.5 South America Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Subcutaneous Drug Delivery Devices Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
5.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Type (2018-2029)
5.3 Global Subcutaneous Drug Delivery Devices Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
6.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Application (2018-2029)
6.3 Global Subcutaneous Drug Delivery Devices Average Price by Application (2018-2029)

7 North America
7.1 North America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
7.2 North America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
7.3 North America Subcutaneous Drug Delivery Devices Market Size by Country
7.3.1 North America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
8.2 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
8.3 Europe Subcutaneous Drug Delivery Devices Market Size by Country
8.3.1 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Subcutaneous Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
10.2 South America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
10.3 South America Subcutaneous Drug Delivery Devices Market Size by Country
10.3.1 South America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Subcutaneous Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Subcutaneous Drug Delivery Devices Market Drivers
12.2 Subcutaneous Drug Delivery Devices Market Restraints
12.3 Subcutaneous Drug Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Subcutaneous Drug Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Subcutaneous Drug Delivery Devices
13.3 Subcutaneous Drug Delivery Devices Production Process
13.4 Subcutaneous Drug Delivery Devices Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Subcutaneous Drug Delivery Devices Typical Distributors
14.3 Subcutaneous Drug Delivery Devices Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Subcutaneous Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Subcutaneous Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BD Basic Information, Manufacturing Base and Competitors
Table 4. BD Major Business
Table 5. BD Subcutaneous Drug Delivery Devices Product and Services
Table 6. BD Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BD Recent Developments/Updates
Table 8. Insulet Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Insulet Corporation Major Business
Table 10. Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services
Table 11. Insulet Corporation Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Insulet Corporation Recent Developments/Updates
Table 13. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 14. Enable Injections Major Business
Table 15. Enable Injections Subcutaneous Drug Delivery Devices Product and Services
Table 16. Enable Injections Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Enable Injections Recent Developments/Updates
Table 18. West Pharmaceutical Services, Inc Basic Information, Manufacturing Base and Competitors
Table 19. West Pharmaceutical Services, Inc Major Business
Table 20. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services
Table 21. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. West Pharmaceutical Services, Inc Recent Developments/Updates
Table 23. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 24. Ypsomed AG Major Business
Table 25. Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services
Table 26. Ypsomed AG Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ypsomed AG Recent Developments/Updates
Table 28. Elcam Medical Basic Information, Manufacturing Base and Competitors
Table 29. Elcam Medical Major Business
Table 30. Elcam Medical Subcutaneous Drug Delivery Devices Product and Services
Table 31. Elcam Medical Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Elcam Medical Recent Developments/Updates
Table 33. Amgen Basic Information, Manufacturing Base and Competitors
Table 34. Amgen Major Business
Table 35. Amgen Subcutaneous Drug Delivery Devices Product and Services
Table 36. Amgen Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Amgen Recent Developments/Updates
Table 38. Wilhelm Haselmeier Basic Information, Manufacturing Base and Competitors
Table 39. Wilhelm Haselmeier Major Business
Table 40. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services
Table 41. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Wilhelm Haselmeier Recent Developments/Updates
Table 43. Global Subcutaneous Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Subcutaneous Drug Delivery Devices Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 46. Market Position of Manufacturers in Subcutaneous Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Subcutaneous Drug Delivery Devices Production Site of Key Manufacturer
Table 48. Subcutaneous Drug Delivery Devices Market: Company Product Type Footprint
Table 49. Subcutaneous Drug Delivery Devices Market: Company Product Application Footprint
Table 50. Subcutaneous Drug Delivery Devices New Market Entrants and Barriers to Market Entry
Table 51. Subcutaneous Drug Delivery Devices Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Subcutaneous Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Subcutaneous Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Subcutaneous Drug Delivery Devices Average Price by Region (2018-2023) & (USD/Unit)
Table 57. Global Subcutaneous Drug Delivery Devices Average Price by Region (2024-2029) & (USD/Unit)
Table 58. Global Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Subcutaneous Drug Delivery Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Subcutaneous Drug Delivery Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Subcutaneous Drug Delivery Devices Average Price by Type (2018-2023) & (USD/Unit)
Table 63. Global Subcutaneous Drug Delivery Devices Average Price by Type (2024-2029) & (USD/Unit)
Table 64. Global Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Subcutaneous Drug Delivery Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Subcutaneous Drug Delivery Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Subcutaneous Drug Delivery Devices Average Price by Application (2018-2023) & (USD/Unit)
Table 69. Global Subcutaneous Drug Delivery Devices Average Price by Application (2024-2029) & (USD/Unit)
Table 70. North America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Subcutaneous Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Subcutaneous Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Subcutaneous Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Subcutaneous Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Subcutaneous Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Subcutaneous Drug Delivery Devices Raw Material
Table 111. Key Manufacturers of Subcutaneous Drug Delivery Devices Raw Materials
Table 112. Subcutaneous Drug Delivery Devices Typical Distributors
Table 113. Subcutaneous Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Subcutaneous Drug Delivery Devices Picture
Figure 2. Global Subcutaneous Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Type in 2022
Figure 4. Prefilled Injectable Examples
Figure 5. Filled Injectable Examples
Figure 6. Global Subcutaneous Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Others Examples
Figure 11. Global Subcutaneous Drug Delivery Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Subcutaneous Drug Delivery Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Subcutaneous Drug Delivery Devices Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Subcutaneous Drug Delivery Devices Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Subcutaneous Drug Delivery Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Subcutaneous Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Subcutaneous Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Subcutaneous Drug Delivery Devices Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Subcutaneous Drug Delivery Devices Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Subcutaneous Drug Delivery Devices Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Subcutaneous Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Subcutaneous Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 53. China Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Subcutaneous Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Subcutaneous Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Subcutaneous Drug Delivery Devices Market Drivers
Figure 74. Subcutaneous Drug Delivery Devices Market Restraints
Figure 75. Subcutaneous Drug Delivery Devices Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Devices in 2022
Figure 78. Manufacturing Process Analysis of Subcutaneous Drug Delivery Devices
Figure 79. Subcutaneous Drug Delivery Devices Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now